Proposal to list a range of medical devices supplied by BSN Medical Limited
Te Pātaka Whaioranga - Pharmac is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule.
What we’re proposing
Pharmac is seeking feedback on a proposal to list medical devices supplied by BSN Medical Limited trading as Essity New Zealand (“BSN Medical”) in Part III of Section H of the Pharmaceutical Schedule from 1 November 2023.
We propose to list medical devices supplied in the following categories:
- Adhesives, sealants and haemostats; and
- Rehabilitation equipment, patient positioning products and supports (“rehabilitation products”)
Consultation closes at 4pm Thursday 7 September 2023 and feedback can be emailed to firstname.lastname@example.org.
What would the effect be?
From 1 November 2023, medical devices supplied by BSN Medical would be listed under a proposed national agreement for all Te Whatu Ora hospitals to purchase under, subject to consultation and approval by Pharmac’s Board or delegate (“Agreement”).
The Agreement would not be for sole supply and Te Whatu Ora hospitals could continue to purchase other suppliers’ brands of adhesives, sealants and haemostats and rehabilitation products.
The Agreement would supersede any existing Te Whatu Ora contracts with BSN Medical for the products included in the Agreement. Any medical devices listed in the Agreement and purchased by Te Whatu Ora hospitals would be in accordance with the terms and conditions, including price, stated in the Agreement effective from the date of listing on the Pharmaceutical Schedule.
Pricing for the medical devices in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- Te Whatu Ora staff including but not limited to:
- Clinical engineers and maintenance services
- Emergency service personnel
- General ward clinicians and nurses
- Neurologists and Neurosurgeons
- Occupational therapists
- Operating theatre nurses
- Orthopaedic surgeons
- Procurement officers and supply chain personnel
- Rehabilitation physicians (including spinal units)
- Speech-language therapists
- Suppliers and wholesalers
About the medical devices
Adhesives, sealants and haemostats
Adhesives, sealants, and haemostats are medical devices used in surgical and non-surgical procedures to achieve haemostasis, tissue sealing, fixation and/or wound closure. The products vary, relating to their purpose, function, composition, application, and clinical indication. There are adhesive, sealant, and haemostat products used in general surgical applications, as well as products designed and used for specific clinical indications/specialty areas.
Rehabilitation is the process of regaining strength or relearning skills after a serious injury, illness, or surgery. Rehabilitation crosses all age groups, though the type, level and goals of rehabilitation will differ depending on the individual needs. Rehabilitation often focuses on:
- physical therapy to help with strength, mobility, and fitness;
- occupational therapy to help with daily activities;
- speech-language therapy to help with speaking, understanding, reading, writing, and swallowing;
- cognitive therapy (following head injury); and
- treatment of pain.
Why we’re proposing this
These products are set out in the rehabilitation products subcategories:
- Podiatry orthotics and specialised footwear
- Immobilisers, bracing and support devices
The RFPs were for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers who responded to the RFPs to seek provisional agreements. This proposal consists of the latest agreements to arise from these processes.
Details about our proposal
The proposal would result in listing 119 medical devices supplied by BSN Medical on the Pharmaceutical Schedule as follows:
Medical devices category
Adhesives, sealants and haemostats
Further information, including pricing and contractual details, has been provided to Te Whatu Ora Procurement personnel. Clinicians interested in further detail on what this change means for their hospital should engage with their Procurement teams.
To provide feedback
Send us an email: email@example.com by 4pm 7 September 2023.
All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.
We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.